CLINICAL_TRIALS
trial_result
· 2006-09-19
Clinical Trial Update: The Plenaxis® Experience Study [Phase 4]
Summary
Phase 4 trial of Plenaxis (abarelix) for prostate cancer has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PRAECIS Pharmaceuticals Inc. | Conditions: Prostate Cancer | Phase 4 | Status: SUSPENDED